3
Announcements
Trials
Browse
Landscape
Status
Suspended
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Neoplasms
4
Lung Neoplasms
4
Carcinoma, Non-Small-Cell Lung
3
Breast Neoplasms
3
Lymphoma
2
Head and Neck Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Squamous Cell
2
Brain Neoplasms
2
Adenocarcinoma
2
Urticaria
1
Tuberous Sclerosis
1
Thrombosis
1
Squamous Cell Carcinoma of Head and Neck
1
Smoking
1
Small Cell Lung Carcinoma
1
Severe Combined Immunodeficiency
1
Sarcoma
1
Salivary Gland Neoplasms
1
Renal Insufficiency, Chronic
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Primary Dysautonomias
1
Polycythemia Vera
1
Polycythemia
1
Polycystic Ovary Syndrome
1
Pancreatitis, Chronic
1
Pancreatitis
1
Pancreatic Cyst
1
Ovarian Neoplasms
1
Interventions
Metformin
7
Surveys and Questionnaires
3
Nutrition Assessment
3
Exercise
3
Tirzepatide
2
Therapeutics
2
Tablets
2
Standard of Care
2
Specimen Handling
2
Resistance Training
2
Methods
2
Interviews as Topic
2
Glucose Tolerance Test
2
Educational Status
2
Biopsy
2
tocilizumab
1
tislelizumab
1
pembrolizumab
1
epalrestat
1
donafenib
1
amlodipine, atorvastatin drug combination
1
Verapamil
1
Urine Specimen Collection
1
Testosterone
1
Secretin
1
Second Harmonic Generation Microscopy
1
Risk Assessment
1
Remote Consultation
1
Preventive Health Services
1
Practice Guidelines as Topic
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Diabetes Mellitus
×
Phlebotomy
×
Clear all
NCT04306939
2026-01-07
GREAT1
University of Pittsburgh
Suspended
120,000 enrolled